Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Prothena Corp Public (PRTA) over the last 8 years, with Q3 2025 value amounting to $2000.0.

  • Prothena Corp Public's Gains from Investment Securities fell 9976.08% to $2000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 2947.76%. This contributed to the annual value of $3.2 million for FY2024, which is 1674.54% down from last year.
  • Per Prothena Corp Public's latest filing, its Gains from Investment Securities stood at $2000.0 for Q3 2025, which was down 9976.08% from $941000.0 recorded in Q2 2025.
  • Prothena Corp Public's Gains from Investment Securities' 5-year high stood at $3.5 million during Q3 2023, with a 5-year trough of -$2000.0 in Q1 2025.
  • In the last 5 years, Prothena Corp Public's Gains from Investment Securities had a median value of $368000.0 in 2021 and averaged $697625.0.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 227500.0% in 2022, then tumbled by 11000.0% in 2025.
  • Prothena Corp Public's Gains from Investment Securities (Quarter) stood at $12000.0 in 2021, then skyrocketed by 2275.0% to $285000.0 in 2022, then surged by 1119.65% to $3.5 million in 2023, then crashed by 78.14% to $760000.0 in 2024, then tumbled by 99.74% to $2000.0 in 2025.
  • Its last three reported values are $2000.0 in Q3 2025, $941000.0 for Q2 2025, and -$2000.0 during Q1 2025.